UK Health Security Agency

UK Health Security Agency
source
Name	UK Health Security Agency
Formation	2021
Predecessor	Public Health England
Type	Executive agency
Headquarters	London
Region served	United Kingdom
Leader title	Chief Executive
Leader name	Jenny Harries
Parent organisation	Department of Health and Social Care

Contents

UK Health Security Agency

The UK Health Security Agency is an executive agency established in 2021 to lead national responses to biological threats, infectious diseases, and health protection in the United Kingdom. It was created following inquiries into the handling of the COVID-19 pandemic and restructured from predecessor agencies to focus on prevention, preparedness and emergency response. The agency works alongside the National Health Service (England), devolved administrations in Scotland, Wales, and Northern Ireland, and international partners such as the World Health Organization, European Centre for Disease Prevention and Control, and Centers for Disease Control and Prevention.

History

The agency was formed in April 2021 as part of post-COVID-19 pandemic reforms that followed the Bibliography of the COVID-19 pandemic inquiries and reviews including the Gale Review and recommendations linked to the Public Health England legacy. Its creation responded to lessons from outbreaks such as SARS, Middle East respiratory syndrome, H1N1 influenza pandemic (2009–2010), and the recent COVID-19 pandemic. Early organisational roots trace back to institutions including the Public Health Laboratory Service and the Health Protection Agency that emerged from public health reconfigurations after events like the Chernobyl disaster and concerns about bioterrorism. Prominent figures involved in public health reform debates have included Chris Whitty, Patrick Vallance, and ministers from the Department of Health and Social Care.

The agency is an executive agency of the Department of Health and Social Care with a board and a Chief Executive accountable to ministers such as the Secretary of State for Health and Social Care. Its governance framework references legislation like the Health and Social Care Act 2012 for system integration with National Health Service (England). Regional coordination involves Public Health Wales, Public Health Scotland, and the Public Health Agency (Northern Ireland), and it liaises with local authorities including Greater London Authority and unitary councils. Scientific leadership draws on advisory bodies such as the Joint Committee on Vaccination and Immunisation and panels featuring experts who have served on inquiries like the UK COVID-19 Inquiry.

Core responsibilities include surveillance of infectious threats such as SARS-CoV-2, influenza, tuberculosis, and vaccine-preventable diseases covered by programmes like those advised by the Joint Committee on Vaccination and Immunisation. The agency manages laboratory networks originating from the Public Health Laboratory Service and collaborates with regional NHS laboratories, academic institutions like Imperial College London and London School of Hygiene & Tropical Medicine, and specialist centres including the National Infection Service. It conducts health protection actions during incidents such as chemical events, radiological hazards exemplified by responses informed by Chernobyl disaster experience, and zoonotic outbreaks linked to events like H5N1 avian influenza.

The agency implements immunisation programmes in line with schedules advised by the Joint Committee on Vaccination and Immunisation and supports screening initiatives that interface with bodies such as the National Screening Committee. It runs campaigns on antimicrobial resistance informed by the Review on Antimicrobial Resistance and collaborates on preparedness exercises with organisations like NHS England, Ministry of Defence, and international partners including the World Health Organization. Other initiatives include travel health advice tied to agencies like the Foreign, Commonwealth and Development Office and targeted community work with charities such as the British Red Cross and research consortia from universities including University of Oxford.

Surveillance systems incorporate genomic sequencing collaborations with the COVID-19 Genomics UK Consortium, laboratory science partnerships with institutions such as Wellcome Trust–funded centres and data linkages to NHS datasets and the UK Biobank. The agency maintains and publishes epidemiological surveillance similar to historical reporting by Public Health England and works with the Office for National Statistics on mortality and population datasets. Research partnerships span universities including University College London, University of Cambridge, and King's College London, and it engages with global initiatives including the Global Health Security Agenda.

The agency has faced criticism about its handling of the COVID-19 pandemic transition from its predecessor, with scrutiny in media outlets and inquiries such as the UK COVID-19 Inquiry and debates in the House of Commons. Critiques have addressed data transparency raised by academics at institutions like Imperial College London and London School of Hygiene & Tropical Medicine, resourcing and workforce concerns voiced by trade unions and professional bodies including the Royal College of Physicians and Royal Society of Biology, and organisational change impacts cited by local public health directors and councils. International commentators compared its model with agencies like the Centers for Disease Control and Prevention and the European Centre for Disease Prevention and Control, prompting discussion about statutory powers, independence, and accountability in parliamentary debates and policy papers.